Viridian Therapeutics, Inc./DE
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2013 | $5.5M | $-197.0K | $-2.2M |
| FY2014 | $6.5M | $-6.9M | $-7.9M |
| FY2015 | $5.7M | $-11.2M | $-11.3M |
| FY2016 | $3.5M | $-17.0M | $-17.3M |
| FY2017 | $4.0M | $-26.5M | $-26.5M |
| FY2018 | $8.4M | $-33.1M | $-32.7M |
| FY2019 | $4.5M | $-42.0M | $-41.9M |
| FY2020 | $1.1M | $-110.4M | $-110.7M |
| FY2021 | $3.0M | $-79.7M | $-79.4M |
| FY2022 | $1.8M | $-134.3M | $-129.9M |
| FY2023 | $314.0K | $-254.5M | $-237.7M |
| FY2024 | $302.0K | $-299.0M | $-269.9M |
| FY2025 | $70.8M | $-363.4M | $-342.6M |